Spero Therapeutics (SPRO) EBITDA Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | -267,092.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -267,092.00 |
| Dec 31, 2025 | -34,341.00 |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 30,568.00 |
| Mar 31, 2025 | -9,990.00 |
| Dec 31, 2024 | -16,203.00 |
| Sep 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | 11,576.00 |
| Mar 31, 2024 | 579,800.00 |
| Dec 31, 2023 | -8,149.00 |
| Sep 30, 2023 | -88,818.00 |
| Jun 30, 2023 | 100,018.00 |
| Mar 31, 2023 | -436,198.00 |
| Dec 31, 2022 | 34,894.00 |
| Sep 30, 2022 | -376,294.00 |
| Jun 30, 2022 | -55,702.00 |
| Mar 31, 2022 | -132,089.00 |
| Sep 30, 2021 | 5.30 Mn |
| Jun 30, 2021 | 12,959.00 |
| Mar 31, 2021 | 110,336.00 |
| Sep 30, 2020 | -4.95 Mn |
| Jun 30, 2020 | 1.86 Mn |
| Mar 31, 2020 | -130,403.00 |
| Dec 31, 2019 | -296,352.00 |
| Sep 30, 2019 | 121,001.00 |
| Jun 30, 2019 | -1.75 Mn |
| Dec 31, 2018 | 76,986.00 |
| Sep 30, 2018 | 5,757.00 |
| Jun 30, 2018 | 177,358.00 |
| Dec 31, 2017 | -1.50 Mn |
| Sep 30, 2017 | 626,509.00 |